Your browser doesn't support javascript.
loading
Neutralizing activity of Usnic acid and ß-cyclodextrins complex against SARS-CoV-2 spike pseudovirus.
Rosa, Luigi; Cutone, Antimo; Galla, Rebecca; Uberti, Francesca; Valenti, Piera.
Afiliação
  • Rosa L; Department of Public Health and Infectious Diseases, University of Rome La Sapienza, Rome, Italy.
  • Cutone A; Department of Biosciences and Territory, University of Molise, Pesche, Italy.
  • Galla R; Laboratory of Physiology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Uberti F; Noivita srls, spin-off, Novara, Italy.
  • Valenti P; Laboratory of Physiology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Nat Prod Res ; : 1-6, 2023 Jul 12.
Article em En | MEDLINE | ID: mdl-37436919
The rapid spread of SARS-CoV-2 and its infection severity require an urgent development of antiviral agents. In this respect, Usnic acid (UA), a natural dibenzofuran derivative, exerts antiviral activity against several viruses, though presenting very low solubility and high cytotoxicity. Here, UA was complexed with ß-cyclodextrins (ß-CDs), a pharmaceutical excipient used to improve drug solubility. The cytotoxic activity, tested on Vero E6 cells, revealed no effect for ß-CDs alone whereas significant cytotoxicity for the UA/ß-CDs complex was recorded at concentrations ≥ 0.05%. The neutralizing activity towards the fusion of SARS-CoV-2 Spike Pseudovirus showed no effects for ß-CDs alone whereas the UA/ß-CDs complex, when pre-incubated with the viral particles, efficiently inhibited the Pseudoviral fusion of about 90 and 82% at non-cytotoxic concentrations of 0.03 and 0.01%, respectively. In conclusion, although further evidences are needed to clarify the exact inhibition mechanism, UA/ß-CDs complex could be useful in SARS-CoV-2 infection.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article